I asked Clayton "Does this discussion between the DSMB and Clinical Steering Committee have anything to do with the allowance of the FDA to include US patients in BETonMACE? When will we shareholders be told what the changes, if any, to the BETonMACE protocol (enrollment, target MACE, timelines) are?"

He replied "When a decision has been finalized, the Company will announce it in a press release."

So no answer to the first question but some clarity on the second.

BearDownAZ